Short-Term Administration Of Jak2 Inhibitors Reduces Splenomegaly In Mouse Models Of Beta-Thalassemia Intermedia And Major

β-thalassemia is one of the most common congenital red blood cell (RBC) disorders characterized by limited β-globin synthesis and ineffective erythropoiesis.[1][1] Based on the requirements for blood transfusion, the disease can be classified as non-transfusion dependent thalassemia (NTDT), or